Indiana toddler suffers severe brain damage after exposure to unregulated 7-OH kratom product

Key points

• Auburn police charged 20-year-old Kole Schwarz with neglect of a dependent resulting in catastrophic injury after a two-year-old boy suffered severe brain damage from 7-OH exposure.
• The child was rushed to a hospital in DeKalb County on September 6, unresponsive and placed in a medically induced coma, before being transferred to Riley Hospital in Indianapolis.
• Schwarz admitted to buying tablets sold as 7-OH under the counter through a contact in Fort Wayne, stating the tablets remained sealed in his pocket, though investigators identified the product as the likely source of exposure.
• The child’s mother cooperated with the investigation and is not a suspect; she told detectives she believed Schwarz used 7-OH and was concerned the toddler may have ingested one.
• The FDA warned about the concerning proliferation of concentrated 7-OH products sold over the counter and online, noting that 7-OH acts like an opioid and can cause severe withdrawal symptoms, seizures, liver toxicity, and overdose.
• 7-OH is illegal in Indiana but is sold as gummies, drinks, and pills in Michigan, where Berrien County health officials recently warned that kratom-related hospitalizations are rising and there is no statewide age limit.

Background

This incident follows earlier coverage of the same case in late October 2026, which detailed the initial charges against Kole Schwarz and the FDA’s warnings about unregulated 7-OH products. The case highlights ongoing concerns about the accessibility of potent kratom-derived substances to children, particularly in states with varying regulatory frameworks. Previous archive articles on childhood exposure to harmful substances, such as lead and sugar, underscore the long-term neurological impacts of early toxic exposure, though 7-OH presents an acute, immediate risk distinct from those chronic conditions.

Why it matters

The case underscores the urgent public health threat posed by unregulated 7-OH products, which are marketed as energy boosters or pain relievers but carry severe risks, including overdose and catastrophic injury. The FDA’s call for immediate regulatory action and consumer education highlights the need for stricter controls on kratom-derived substances, especially given their availability in neighboring states like Michigan. The incident also raises concerns about the safety of children in households where such substances are present, emphasizing the need for clearer labeling and age restrictions to prevent accidental exposure.

What to watch

The FDA is expected to pursue regulatory actions to limit access to 7-OH-containing products and educate consumers about the risks. Michigan health officials may consider implementing age limits or stricter regulations in response to rising kratom-related hospitalizations. The case may also prompt further scrutiny of over-the-counter sales of kratom products in states where they are legal, potentially leading to broader legislative changes to protect children from accidental exposure.